MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290,399,971 | +44.7% | 6,666,666 | +20.0% | 4.53% | +66.4% |
| Q2 2023 | $200,722,202 | -2.8% | 5,555,555 | 0.0% | 2.72% | -11.1% |
| Q1 2023 | $206,555,535 | -17.9% | 5,555,555 | 0.0% | 3.06% | -18.6% |
| Q4 2022 | $251,722,197 | -35.1% | 5,555,555 | +0.1% | 3.76% | -47.5% |
| Q3 2022 | $387,651,000 | +4.0% | 5,550,555 | 0.0% | 7.16% | -2.7% |
| Q2 2022 | $372,609,000 | -14.9% | 5,550,555 | +4.2% | 7.36% | -7.9% |
| Q1 2022 | $437,822,000 | -41.2% | 5,325,000 | +4.9% | 7.99% | -36.9% |
| Q4 2021 | $744,452,000 | -15.8% | 5,075,000 | +1.5% | 12.67% | -8.8% |
| Q3 2021 | $884,550,000 | +9.5% | 5,000,000 | 0.0% | 13.90% | -1.1% |
| Q2 2021 | $807,650,000 | +0.9% | 5,000,000 | +7.0% | 14.05% | +1.6% |
| Q1 2021 | $800,828,000 | -19.6% | 4,675,000 | +3.1% | 13.83% | -19.4% |
| Q4 2020 | $996,067,000 | +38.1% | 4,535,000 | +4.4% | 17.15% | +67.4% |
| Q3 2020 | $721,155,000 | +47.3% | 4,343,000 | +1.3% | 10.25% | +5.9% |
| Q2 2020 | $489,420,000 | +54.8% | 4,286,765 | +4.2% | 9.68% | -9.3% |
| Q1 2020 | $316,143,000 | -36.3% | 4,112,700 | +6.8% | 10.67% | -26.8% |
| Q4 2019 | $496,137,000 | +69.8% | 3,850,200 | +2.7% | 14.57% | +19.5% |
| Q3 2019 | $292,163,000 | -26.6% | 3,750,000 | -2.9% | 12.19% | -11.4% |
| Q2 2019 | $397,838,000 | +40.5% | 3,862,500 | 0.0% | 13.75% | +12.3% |
| Q1 2019 | $283,121,000 | +39.1% | 3,862,500 | -19.5% | 12.24% | +0.6% |
| Q4 2018 | $203,535,000 | -9.9% | 4,798,101 | 0.0% | 12.17% | +17.2% |
| Q3 2018 | $225,991,000 | -4.5% | 4,798,101 | 0.0% | 10.38% | +14.0% |
| Q2 2018 | $236,546,000 | +75.2% | 4,798,101 | +9.1% | 9.11% | +41.2% |
| Q1 2018 | $135,022,000 | +68.2% | 4,398,101 | 0.0% | 6.45% | +23.9% |
| Q4 2017 | $80,265,000 | +84.9% | 4,398,101 | +18.5% | 5.20% | +54.5% |
| Q3 2017 | $43,414,000 | +422.7% | 3,710,601 | +63.1% | 3.37% | +221.0% |
| Q2 2017 | $8,305,000 | -33.0% | 2,275,401 | -4.5% | 1.05% | -33.7% |
| Q1 2017 | $12,393,000 | +73.0% | 2,383,201 | +58.0% | 1.58% | +9.4% |
| Q4 2016 | $7,164,000 | -27.2% | 1,508,201 | +1.3% | 1.45% | -16.2% |
| Q3 2016 | $9,839,000 | +48.3% | 1,488,487 | +22.5% | 1.73% | +17.1% |
| Q2 2016 | $6,633,000 | -77.9% | 1,214,833 | -13.5% | 1.47% | -85.9% |
| Q1 2016 | $30,047,000 | -24.4% | 1,404,055 | +11.6% | 10.48% | -23.5% |
| Q4 2015 | $39,755,000 | -20.5% | 1,258,055 | -13.4% | 13.70% | +5.3% |
| Q3 2015 | $50,014,000 | +58.9% | 1,453,055 | +45.3% | 13.00% | +50.0% |
| Q2 2015 | $31,470,000 | +234.5% | 1,000,000 | +211.7% | 8.67% | +140.1% |
| Q1 2015 | $9,408,000 | – | 320,867 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |